Dambkowski Carl — SEC Form 4 filings
SEC reporting owner CIK 1983476. 37 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 37 filings on record, filed 2024-07-05 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 62 legs across 30 filings — 328,970 shares, $22,320,388 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 45.
- Largest priced transaction: sale of 26,400 shares @ $132.60 ($3,500,640) in Apogee Therapeutics, Inc., filed 2026-06-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Apogee Therapeutics, Inc. (APGE) | Chief Medical Officer | 32 | — | 57 legs · 188,970 sh · $13,674,640 | 36 |
| Oruka Therapeutics, Inc. (ORKA) | Director | 5 | — | 5 legs · 140,000 sh · $8,645,748 | 9 |
Form 4 filings — Dambkowski Carl
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Disposition to issuer (D): 1,375 @ $135.06 · Disposition to issuer (D): 167,123 · Disposition to issuer (D): 110,665 (derivative) · Disposition to issuer (D): 124,962 (derivative) · Disposition to issuer (D): 83,690 (derivative) | EDGAR |
| 2026-08-07 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 4,125 @ $22.86 · Sale (S): 5,500 @ $134.17 · Option exercise (M): 4,125 (derivative) @ $0 | EDGAR |
| 2026-07-16 | 4 | Apogee Therapeutics, Inc. (APGE) | Gift (G): 8,000 @ $0 | EDGAR |
| 2026-07-02 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 4,125 @ $22.86 · Sale (S): 5,500 @ $132.74 · Option exercise (M): 4,125 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 26,400 @ $132.60 | EDGAR |
| 2026-06-12 | 4 | Oruka Therapeutics, Inc. (ORKA) | Sale (S): 22,417 @ $70.13 · Sale (S): 12,583 @ $70.11 | EDGAR |
| 2026-06-05 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 4,125 @ $22.86 · Sale (S): 5,500 @ $78.71 · Option exercise (M): 4,125 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 9,136 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 38,689 @ $6.84 · Option exercise (M): 11,904 @ $7.80 · Option exercise (M): 11,667 @ $11.77 · Sale (S): 38,318 @ $58.43 · Sale (S): 53,447 @ $59.10 · Sale (S): 13,235 @ $59.97 · +3 more | EDGAR |
| 2026-05-08 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 4,125 @ $22.86 · Sale (S): 3,700 @ $83.92 · Sale (S): 1,800 @ $84.60 · Option exercise (M): 4,125 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 4,125 @ $22.86 · Sale (S): 2,698 @ $84.31 · Sale (S): 2,702 @ $85.33 · Sale (S): 100 @ $85.89 · Option exercise (M): 4,125 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 4,125 @ $22.86 · Sale (S): 3,225 @ $70.33 · Sale (S): 2,075 @ $71.98 · Sale (S): 200 @ $73.26 · Option exercise (M): 4,125 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 4,125 @ $22.86 · Sale (S): 2,481 @ $64.88 · Sale (S): 1,420 @ $65.83 · Sale (S): 1,299 @ $66.85 · Sale (S): 100 @ $67.88 · Sale (S): 200 @ $68.94 · +1 more | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Other (J): 116,483 @ $0 | EDGAR |
| 2026-01-09 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 14,025 @ $22.86 · Sale (S): 2,954 @ $77.13 · Sale (S): 14,820 @ $77.90 · Sale (S): 826 @ $79.04 · Sale (S): 100 @ $80.06 · Option exercise (M): 14,025 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Apogee Therapeutics, Inc. (APGE) | Grant/award (A): 83,690 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 10,900 @ $75 | EDGAR |
| 2025-11-07 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 8,060 @ $22.86 · Sale (S): 2,300 @ $53.62 · Sale (S): 2,200 @ $54.83 · Sale (S): 5,607 @ $55.58 · Sale (S): 678 @ $56.51 · Option exercise (M): 8,060 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 2,385 @ $22.86 · Sale (S): 5,110 @ $39.80 · Option exercise (M): 2,385 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,535 @ $37.82 · Sale (S): 190 @ $38.55 | EDGAR |
| 2025-08-08 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,725 @ $37.78 | EDGAR |
| 2025-07-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 7,365 @ $22.86 · Sale (S): 6,409 @ $44.77 · Sale (S): 2,935 @ $45.49 · Sale (S): 746 @ $46.26 · Option exercise (M): 7,365 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,725 @ $36.96 | EDGAR |
| 2025-06-03 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,725 @ $35.75 | EDGAR |
| 2025-04-04 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 2,471 @ $35.56 · Sale (S): 500 @ $37.03 · Sale (S): 889 @ $37.59 | EDGAR |
| 2025-03-07 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 1,590 @ $30.48 | EDGAR |
| 2025-02-07 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 795 @ $22.86 · Sale (S): 3,520 @ $40.69 · Option exercise (M): 795 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 1,360 @ $22.86 · Sale (S): 1,499 @ $46.42 · Sale (S): 2,486 @ $47.21 · Sale (S): 100 @ $47.92 · Option exercise (M): 1,360 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | Apogee Therapeutics, Inc. (APGE) | Option exercise (M): 1,815 @ $22.86 · Sale (S): 4,085 @ $48.62 · Sale (S): 455 @ $50 · Option exercise (M): 1,815 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Apogee Therapeutics, Inc. (APGE) | Grant/award (A): 124,962 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 6,665 @ $46.07 | EDGAR |
| 2024-11-08 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 5,326 @ $58.91 · Sale (S): 1,339 @ $59.96 | EDGAR |
| 2024-10-04 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 5,740 @ $56.16 · Sale (S): 925 @ $56.86 | EDGAR |
| 2024-09-06 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 5,878 @ $47.49 · Sale (S): 787 @ $48.06 | EDGAR |
| 2024-08-09 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 6,523 @ $40.47 · Sale (S): 142 @ $41.09 · Sale (S): 670 @ $42.56 | EDGAR |
| 2024-07-05 | 4 | Apogee Therapeutics, Inc. (APGE) | Sale (S): 3,852 @ $37.29 · Sale (S): 2,143 @ $38.16 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1983476 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →